Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bavisant in Adults with ADHD
NCT00566449Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bavisant in attention deficit hyperactivity disorder (ADHD), sponsored by Johnson & Johnson. Started Dec 2007; status: completed.
02
Drugs
bavisant
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00566449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566449.